Memory Archives

Chewing ability linked to reduced dementia risk

Chewing ability linked to reduced dementia risk — Can you bite into an apple? If so, you are more likely to maintain mental abilities. – Can you bite into an apple? If so, you are more likely to maintain mental abilities, according to new research from Karolinska Institutet. The population is ageing, and the older we become the more likely it is that we risk deterioration of our cognitive functions, such as memory, decision-making and problem solving.

Exercise improves memory and thinking after stroke

Exercise improves memory, thinking after stroke, study finds – Just six months of exercise can improve memory, language, thinking and judgment problems by almost 50 per cent. Toronto researchers found that the proportion of stroke patients with at least mild cognitive impairment dropped from 66 per cent to 37 per cent during a research study on the impact of exercise on the brain.

Binge drinking increases cognitive decline in older adults

Binge drinking increases the risk of cognitive decline in older adults – Researchers from the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, suggesting a link between binge drinking in older adults and the risk of developing dementia. The work is supported by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care in the South West Peninsula (NIHR PenCLAHRC).

Alzheimer’s Disease timeline invaluable for successful drug trials

First detailed timeline established for brain’s descent into Alzheimer’s – Scientists have assembled the most detailed chronology to date of the human brain’s long, slow slide into full-blown Alzheimer’s disease. As part of an international research partnership known as the Dominantly Inherited Alzheimer’s Network (DIAN), scientists at Washington University and elsewhere evaluated a variety of pre-symptomatic markers of Alzheimer’s disease in 128 subjects from families genetically predisposed to develop the disorder.

Belviq lorcaserin approved to treat overweight or obese adults

FDA approves Belviq to treat some overweight or obese adults – Belviq (lorcaserin hydrochloride) is approved as an addition to a reduced-calorie diet and exercise, for chronic weight management. This obesity drug is approved by US FDA for use in adults with a body mass index (BMI) of 30 or greater (obese), or adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).

Stimulation during sleep can enhance skill learning

Learn that tune while fast asleep — Research shows that stimulation during sleep can enhance skill learning – Want to nail that tune that you’ve practiced and practiced? Maybe you should take a nap with the same melody playing during your sleep, new provocative Northwestern University research suggests. The research grows out of exciting existing evidence that suggests that memories can be reactivated during sleep and storage of them can be strengthened in the process.

New study to find role of stress in development of dementia and Alzheimer’s disease

Stress link to Alzheimer’s goes under the spotlight — A new ?1.5 million study to find role of stress in development of dementia and Alzheimer’s disease – Chronic stress is being investigated in a new Alzheimer’s Society funded research project as a risk factor for developing dementia. It is part of a ?1.5 million package of six grants being given by the charity fighting to find a cause, cure and way to prevent the disease.

Omega 3 fish oil supplements not reducing cognitive decline in older

Role of omega-3 in preventing cognitive decline in older people questioned — Elderly warned that taking fish oil pills ‘does not prevent brain decline’ – Older people who take omega-3 fish oil supplements are probably not reducing their chances of losing cognitive function. Based on the available data from studies lasting up to 3.5 years, the researchers concluded that the supplements offered no benefits for cognitive health over placebo capsules or margarines, but that longer term effects are worth investigating.

Safety changes in labeling for cholesterol lowering drugs statins

FDA Announces Safety Changes in Labeling for Some Cholesterol-Lowering Drugs – Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins are being announced by the U.S. Food and Drug Administration. These products, when used with diet and exercise, help to lower a person’s “bad cholesterol (low-density lipoprotein cholesterol).

Reversing Alzheimer’s gene blockade can restore memory

Reversing Alzheimer’s gene ‘blockade’ can restore memory, other cognitive functions — Neuroscientists show that HDAC2 enzyme could be a good target for new drugs – MIT neuroscientists have shown that an enzyme overproduced in the brains of Alzheimer’s patients creates a blockade that shuts off genes necessary to form new memories. Furthermore, by inhibiting that enzyme in mice, the researchers were able to reverse Alzheimer’s symptoms.

Omega 3 fatty acids linked to aging and memory problems

Fish oil omega-3 fatty acids linked to brain health — A Diet Rich in Fish May Help the Aging Brain – A diet lacking in omega-3 fatty acids, nutrients commonly found in fish, may cause your brain to age faster and lose some of its memory and thinking abilities. Omega-3 fatty acids include the nutrients called docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).

Bexarotene cancer drug may reverse Alzheimer’s symptoms

Drug quickly reverses Alzheimer’s symptoms in mice — Case Western Reserve researchers discover FDA-approved drug rapidly clears amyloid from the brain and reverses cognitive defects – Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer’s disease. The research shows that use of a drug in mice appears to quickly reverse the pathological, cognitive and memory deficits caused by the onset of Alzheimer’s.